Royal Bank of Canada
OKUR

Royal Bank of Canada’s OnKure Therapeutics OKUR Stock Holding History

Royal Bank of Canada’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1K Buy
230
+128
+125% +$395 ﹤0.01% 6995
2025
Q4 		$0 Sell
102
-88
-46% -$263 ﹤0.01% 7775
2025
Q3 		$1K Sell
190
-57
-23% -$141 ﹤0.01% 7058
2025
Q2 		$1K Buy
247
+215
+672% +$564 ﹤0.01% 6963
2025
Q1 		$0 Sell
32
-11
-26% -$62 ﹤0.01% 7334
2024
Q4 		$0 Buy
+43
New +$651 ﹤0.01% 7347
2024
Q3 		– Sell
-1
Closed – – 7592
2024
Q2 		$0 Sell
1
-73
-99% -$1.24K ﹤0.01% 7636
2024
Q1 		$1K Sell
74
-203
-73% -$3.35K ﹤0.01% 6893
2023
Q4 		$4K Buy
277
+79
+40% +$4.92K ﹤0.01% 6702
2023
Q3 		$15K Buy
198
+103
+108% +$7.01K ﹤0.01% 6293
2023
Q2 		$6K Buy
+95
New +$7.65K ﹤0.01% 6640
2022
Q4 		– Sell
-8
Closed – – 7819
2022
Q3 		$0 Buy
8
+6
+300% +$197 ﹤0.01% 7958
2022
Q2 		$0 Sell
2
-51
-96% -$1.19K ﹤0.01% 7793
2022
Q1 		$2K Sell
53
-159
-75% -$8.9K ﹤0.01% 7514
2021
Q4 		$18K Buy
212
+135
+175% +$9.91K ﹤0.01% 6849
2021
Q3 		$6K Buy
77
+34
+79% +$2.88K ﹤0.01% 7103
2021
Q2 		$4K Buy
+43
New +$4.8K ﹤0.01% 7143

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Royal Bank of Canada's OKUR Position: Q1 2026 in Review

Royal Bank of Canada increased its OnKure Therapeutics (OKUR) stake by 125% in Q1 2026, buying an estimated $395 and bringing the position to 230 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #6995.

Royal Bank of Canada first reported a position in OKUR in Q2 2021 and has held it in 17 quarters since. The position peaked at $18K in Q4 2021. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • Royal Bank of Canada held 230 shares of OnKure Therapeutics worth $1K as of Q1 2026.
  • Royal Bank of Canada bought 128 OnKure Therapeutics shares in Q1 2026, an estimated $395.
  • OnKure Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6995 holding.
  • Royal Bank of Canada first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • Royal Bank of Canada's OnKure Therapeutics position peaked at $18K in Q4 2021.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.